(3aS,8aR)-2-(Isoquinolin-3-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 250mg

tert-Butyl (1-(4-bromophenyl)ethyl)carbamate, 95.0%, 100g

Z-Gly-Pro, 95.0%, 5g

2-Amino-2-(4-bromophenyl)acetic acid, 95.0%, 100mg

(2-(Trifluoromethyl)pyrimidin-5-yl)boronic acid, 95.0%, 100mg

tert-Butyl 3-propoxypyrrolidine-1-carboxylate, 97.0%, 250mg

((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(di(naphthalen-1-yl)methanol), 97%, 5g

4-(5-methyl-1,2,4-oxadiazol-3-yl)phenol, 95.0%, 1g

(R)-1-(2-Methyl-3-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 98%, 1g

Chroman-6-carboxylic acid, 95.0%, 250mg

Trial kit Spectra/Por® Biotech CE, 3500–5000 dalton(s), 1 Piece(s)

3-(2,6-Difluorophenyl)-1,2-oxazol-5-amine, 95%, 2.5g

4-(4-Chloro-phenyl)-isoxazol-5-ylamine, 95.0%, 1g